# A Bioequivalence Trial of Irbesartan Tablets（0.15g） in Healthy Chinese Subjects

> **NCT05297929** · PHASE1 · UNKNOWN · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 54 (estimated)

## Conditions studied

- Irbesartan Tablets (0.15g/Tablet)
- Under Fasted Condition
- Under Fed Condition
- Bioequivalence

## Interventions

- **DRUG:** Irbesartan Tablet

## Key facts

- **NCT ID:** NCT05297929
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-17
- **Primary completion:** 2022-04-09
- **Final completion:** 2022-12-31
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2022-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05297929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05297929, "A Bioequivalence Trial of Irbesartan Tablets（0.15g） in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05297929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*